Browse by Phase
Phase 1 Clinical Trials
Phase 1 trials test a new drug or treatment in a small group (20–80 people) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects.
Total Trials
551
Recruiting Now
551
Top Conditions in Phase 1
NCT07230353 Phase 1
Recruiting
A Phase 1b Open-label Study to Evaluate Safety in Participants With Rheumatoid A...
Condition
Rheumatoid Arthritis
Enrollment
47 pts
Location
Georgia, Moldova, New Zealand
Sponsor
Xencor, Inc.
NCT07166081 Phase 1
Recruiting
Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0...
Condition
Non-diabetic Overweight or Obese
Enrollment
80 pts
Location
United States
Sponsor
BrightGene Bio-Medical Technol
NCT07179328 Phase 1
Recruiting
Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grad...
Condition
GBM
Enrollment
10 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen
NCT05819892 Phase 1
Recruiting
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by ...
Condition
Endometrial Cancer
Enrollment
21 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05003895 Phase 1
Recruiting
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Maligna...
Condition
Hepatocellular Carcinoma
Enrollment
38 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05960656 Phase 1
Recruiting
SGLTi, Hepatic Glucose Production and Ketogenesis
Condition
Type 2 Diabetes
Enrollment
30 pts
Location
United States
Sponsor
The University of Texas Health
NCT03863457 Phase 1
Recruiting
[18F] F-GLN by PET/CT in Breast Cancer
Condition
Breast Cancer
Enrollment
40 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn
NCT07256301 Phase 1
Recruiting
A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Pa...
Condition
PNH - Paroxysmal Nocturnal Hemoglobinuria
Enrollment
24 pts
Location
China
Sponsor
Shanghai Lanyi Therapeutics Co
NCT07194044 Phase 1
Recruiting
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Condition
Metastatic Ewing Sarcoma
Enrollment
15 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
NCT07217171 Phase 1
Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 ...
Condition
Bladder Cancer
Enrollment
160 pts
Location
United States
Sponsor
EvolveImmune United, Inc
NCT06414434 Phase 1
Recruiting
BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma
Condition
Liposarcoma
Enrollment
24 pts
Location
United States
Sponsor
Michael Wagner, MD
NCT05725876 Phase 1
Recruiting
Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate th...
Condition
Psoriasis
Enrollment
56 pts
Location
Netherlands
Sponsor
University Medical Center Gron
NCT06463340 Phase 1
Recruiting
Study of SGR-3515 In Participants With Advanced Solid Tumors.
Condition
Advanced Solid Tumor
Enrollment
52 pts
Location
United States, Canada
Sponsor
Schrödinger, Inc.
NCT06293040 Phase 1
Recruiting
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
Condition
Cannabis Intoxication
Enrollment
90 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06673017 Phase 1
Recruiting
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
26 pts
Location
United States
Sponsor
PanTher Therapeutics
NCT05720117 Phase 1
Recruiting
A Study of PYX-201 in Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
330 pts
Location
United States, Belgium, Spain
Sponsor
Pyxis Oncology, Inc
NCT07165002 Phase 1
Recruiting
A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Nor...
Condition
Healthy
Enrollment
32 pts
Location
Hungary, New Zealand, Slovakia
Sponsor
Eli Lilly and Company
NCT05730244 Phase 1
Recruiting
A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against ...
Condition
Tinea Versicolor
Enrollment
20 pts
Location
Jamaica
Sponsor
The University of The West Ind
NCT05877664 Phase 1
Recruiting
Study of ZG0895.HCl in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
60 pts
Location
China
Sponsor
Suzhou Zelgen Biopharmaceutica
NCT06360354 Phase 1
Recruiting
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participa...
Condition
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Enrollment
350 pts
Location
United States, Australia, Belgium
Sponsor
Amgen
NCT05990465 Phase 1
Recruiting
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B...
Condition
Non Hodgkin Lymphoma
Enrollment
12 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT07342881 Phase 1
Recruiting
Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of P...
Condition
Chronic Hepatitis B Infection
Enrollment
30 pts
Location
United States
Sponsor
Aligos Therapeutics
NCT06632236 Phase 1
Recruiting
5G-EMERALD: Amivantamab in Malignant Brain Tumours
Condition
Malignant Primary Gliomas
Enrollment
12 pts
Location
United Kingdom
Sponsor
Institute of Cancer Research,
NCT05292664 Phase 1
Recruiting
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Condition
Myelodysplastic Syndromes, de Novo
Enrollment
30 pts
Location
United States
Sponsor
Andrew E. Place, MD
NCT04521764 Phase 1
Recruiting
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Brea...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
54 pts
Location
United States
Sponsor
Mayo Clinic